The aim of this review is to elucidate the role of mtDNA in the pathogenesis of metabolic syndrome and its components as a key component of mitochondrial dysfunction and to describe the promising and little-studied AAA+ LonP1 protease as a potential target (with possible therapeutic potential) in metabolic disorders. This evidence concerns the gene LONP1 and metabolic syndrome.